Magle Chemoswed Holding Reports Financial Results For Second Quarter 2023
Today, on 18 Julyl 2023, Magle Chemoswed Holding AB (publ) has published its interim report for Q2 2023.
APR-JUN 2023 KEY INDICATORS
- Net sales amounted to 38.1 MSEK (35.5).
- EBITDA equalled 9.5 MSEK (7.7).
- Operating profit (EBIT) is 6.3 MSEK (4.2)
- Profit after tax amounted to 4.7 MSEK (3.8)
- Earnings per share SEK 0,4 (0,4) per share
JAN-JUN 2023 KEY INDICATORS
- Net sales amounted to 76.7 MSEK (65.7).
- EBITDA equalled 17.0 MSEK (15.4).
- Operating profit (EBIT) is 10.6 MSEK (8.8)
- Profit after tax amounted to 7.6 MSEK (7.9)
- Earnings per share SEK 0,7 (0,7) per share
“In the second quarter, we expanded our project portfolio, strong clinical data for SmartPAN® was presented to key opinion leaders, and total revenues from our CDMO business and DSM-based products increased by 7.4 percent compared to the corresponding period last year.” says Justin Pierce, CEO of Magle Group.
The full report is available at https://maglegroup.com/financial-reports/
